KQ-2003 CAR-T Cell Therapy for Relapsed or Refractory Multiple Myeloma

Will this trial show a positive result on objective response rateOutcome measureObjective Response Rate (ORR)Objective response rate is the share of patients whose tumors shrink by a predefined amount. It is useful for early signals and accelerated approval settings, but it is more surrogate than survival outcomes.ClinicalTrials.gov outcome?